We are live on ! Find out more
LABU icon

Direxion Daily S&P Biotech Bull 3X ETF

34 hedge funds and large institutions have $23.3M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more call options, than puts

Call options by funds: $46.3M | Put options by funds: $41.5M

2.27% less ownership

Funds ownership: 6.47%4.19% (-2.3%)

8% less funds holding

Funds holding: 3734 (-3)

27% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 11

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

55% less capital invested

Capital invested by funds: $51.9M → $23.3M (-$28.6M)

Holders
34
Holders Change
-3
Holders Change %
-8.11%
% of All Funds
0.46%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
8
Reduced
11
Closed
8
Calls
$46.3M
Puts
$41.5M
Net Calls
+$4.79M
Net Calls Change
-$8.13M

LABU Hedge Fund Activity: Q1 2025 in Review

34 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q1 2025, worth a combined $23.3M — down 55% from $51.9M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of LABU and 5 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 8 added.

The largest buyer was Jane Street, opening a new position worth an estimated $6.23M. The largest seller was Citadel Advisors, exiting entirely with an estimated $10.3M sold.

  • 34 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q1 2025, down from 37 in Q4 2024.
  • Funds reported $23.3M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q1 2025, down 55% quarter-over-quarter.
  • 5 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q1 2025 and 8 closed out, a net change of -3 holders.
  • The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q1 2025 was Jane Street, an estimated $6.23M added.
  • The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q1 2025 was Citadel Advisors, an estimated $10.3M sold.

Based on aggregated 13F filings for Q1 2025.